Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

New indication for imiquimod (Aldara) topical cream by 3M Pharmaceuticals; NeutroSpec (formerly LeuTech) by Mallinckrodt and Palatin Technologies; Fixed-dose combination treatment of abacavir/lamivudine (Epzicom) and tenofovir disoproxil/emtricitabine (Truvada) by GlaxoSmithKline and Gilead Sciences, respectively.

New FDA Approvals